Hypothalamic pituitary axis disorders are still underestimated in hemodialysis patients. Even though commonly not associated with apparent diseases, they can induce or worsen many complications. The aim of this study was to investigate basic endocrinological disorders among patients with recent deterioration of general condition or hemodynamic disorders. We investigated the endocrine profile of hemodialysis patients with recently exacerbated acute complications, including severe weakness, acute hypotension, severe hypoglycemia and/or the onset of chronic hypotension with no cardiac dysfunction. We analyzed the blood levels of the thyroid-stimulating hormone (TSH), the adrenocorticotropin hormone (ACTH), the growth hormone (GH), the follicle stimulating hormone (FSH), the luteinizing hormone (LH), the prolactin and sexual hormones each time we found a gonadotrophic disorder. Over the 47 patients of our hemodialysis unit, we colligated 15 patients with new symptomatology corresponding to the signs mentionned above. There were 7 males and 8 females, with sex ratio 0,87. Age ranged from 22 to 68 years with an average of 46,5 years. Underlying renal disease consists on an end-stage undetermined glomerulonephritis in 5 cases, membranous glomerulonephritis in one case, Alport syndrome in one case, nephroangiosclerosis in one case, diabetic nephropathy in 2 cases, and tubulointerstitial nephritis in 5 cases. Hemodialysis was carried on for all patients with an average of 152,75 months [55-351months], three times a week, four hours each session, with blood pump flow at 300ml/min and dialysate fluid flow at 500ml/min. Eleven patients were dialysate with high flux membrane, four with medium flux membrane. Symptoms at time of the endocrine check were: severe hypoglycemia in 3 cases, chronic hypotension in 7cases, severe weakness in 8 cases.The mean hormones levels and intervals are summarized in figure1.We noticed peripheric hypothyroidism in 3 patients, moderate hyperprolactinemia in 7 cases, hypergonatrophic hypogonadism in3 cases and hypogonadotrophic hypogonadism in 2 cases. One patient presents an anterior pituitary deficiency with three axes affected (hypogonadotrophic hypogonadism, central adrenal deficiency and central hypothyroidism). All abnormalities found were treated with replacement hormonal therapy. We noticed an improvement in the initial symptomatology in all cases. As kidney function declines, sexual hormones, the hypothalamic–pituitary axis, and the thyroid frequently function aberrantly. The pathogenesis of those disorders is multifactorial, with extrinsic and intrinsic factors. Their screening in hemodialysis patients must be early because of the added risk of many complications’ occurrence. Their management requires multidisciplinary approach.